首页 > 最新文献

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu最新文献

英文 中文
Beyond images: Emerging role of Raman spectroscopy-based artificial intelligence in diagnosis of gastric neoplasia. 超越图像:基于拉曼光谱的人工智能在胃肿瘤诊断中的新兴作用。
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.13
Khek Yu Ho
White-light endoscopy with tissue biopsy is the gold standard interface for diagnosing gastric neoplastic lesions. However, misdiagnosis of lesions is a challenge because of operator variability and learning curve issues. These issues have not been resolved despite the introduction of advanced imaging technologies, including narrow band imaging, and confocal laser endomicroscopy. To ensure consistently high diagnostic accuracy among endoscopists, artificial intelligence (AI) has recently been introduced to assist endoscopists in the diagnosis of gastric neoplasia. Current endoscopic AI systems for endoscopic diagnosis are mostly based upon interpretation of endoscopic images. In real-life application, the image-based AI system remains reliant upon skilful operators who will need to capture sufficiently good quality images for the AI system to analyze. Such an ideal situation may not always be possible in routine practice. In contrast, non-image-based AI is less constraint by these requirements. Our group has recently developed an endoscopic Raman fibre-optic probe that can be delivered into the gastrointestinal tract via the working channel of any endoscopy for Raman measurements. We have also successfully incorporated the endoscopic Raman spectroscopic system with an AI system. Proof of effectiveness has been demonstrated in in vivo studies using the Raman endoscopic system in close to 1,000 patients. The system was able to classify normal gastric tissue, gastric intestinal metaplasia, gastric dysplasia and gastric cancer, with diagnostic accuracy of >85%. Because of the excellent correlation between Raman spectra and histopathology, the Raman-AI system can provide optical diagnosis, thus allowing the endoscopists to make clinical decisions on the spot. Furthermore, by allowing non-expert endoscopists to make real-time decisions as well as expert endoscopists, the system will enable consistency of care.
白光内镜结合组织活检是诊断胃肿瘤病变的金标准界面。然而,由于操作人员的可变性和学习曲线问题,病变的误诊是一个挑战。尽管引入了先进的成像技术,包括窄带成像和共聚焦激光内窥镜检查,这些问题仍未得到解决。为了确保内镜医师的诊断准确性,最近引入了人工智能(AI)来协助内镜医师诊断胃肿瘤。目前用于内镜诊断的内镜人工智能系统大多基于内镜图像的解释。在实际应用中,基于图像的人工智能系统仍然依赖于熟练的操作员,他们需要捕获足够高质量的图像供人工智能系统分析。在日常实践中,这种理想的情况可能并不总是可能的。相比之下,非基于图像的AI较少受到这些要求的约束。我们的团队最近开发了一种内窥镜拉曼光纤探针,可以通过任何内窥镜的工作通道进入胃肠道进行拉曼测量。我们还成功地将内窥镜拉曼光谱系统与人工智能系统结合在一起。在近1000名患者的体内研究中,使用拉曼内窥镜系统证明了其有效性。该系统可对正常胃组织、胃肠化生、胃异常增生和胃癌进行分类,诊断准确率>85%。由于拉曼光谱与组织病理学之间具有良好的相关性,因此拉曼- ai系统可以提供光学诊断,从而使内窥镜医师能够现场做出临床决策。此外,通过允许非专业内窥镜医生和专业内窥镜医生一起做出实时决策,该系统将实现护理的一致性。
{"title":"Beyond images: Emerging role of Raman spectroscopy-based artificial intelligence in diagnosis of gastric neoplasia.","authors":"Khek Yu Ho","doi":"10.21147/j.issn.1000-9604.2022.05.13","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.05.13","url":null,"abstract":"White-light endoscopy with tissue biopsy is the gold standard interface for diagnosing gastric neoplastic lesions. However, misdiagnosis of lesions is a challenge because of operator variability and learning curve issues. These issues have not been resolved despite the introduction of advanced imaging technologies, including narrow band imaging, and confocal laser endomicroscopy. To ensure consistently high diagnostic accuracy among endoscopists, artificial intelligence (AI) has recently been introduced to assist endoscopists in the diagnosis of gastric neoplasia. Current endoscopic AI systems for endoscopic diagnosis are mostly based upon interpretation of endoscopic images. In real-life application, the image-based AI system remains reliant upon skilful operators who will need to capture sufficiently good quality images for the AI system to analyze. Such an ideal situation may not always be possible in routine practice. In contrast, non-image-based AI is less constraint by these requirements. Our group has recently developed an endoscopic Raman fibre-optic probe that can be delivered into the gastrointestinal tract via the working channel of any endoscopy for Raman measurements. We have also successfully incorporated the endoscopic Raman spectroscopic system with an AI system. Proof of effectiveness has been demonstrated in in vivo studies using the Raman endoscopic system in close to 1,000 patients. The system was able to classify normal gastric tissue, gastric intestinal metaplasia, gastric dysplasia and gastric cancer, with diagnostic accuracy of >85%. Because of the excellent correlation between Raman spectra and histopathology, the Raman-AI system can provide optical diagnosis, thus allowing the endoscopists to make clinical decisions on the spot. Furthermore, by allowing non-expert endoscopists to make real-time decisions as well as expert endoscopists, the system will enable consistency of care.","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"539-542"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646455/pdf/cjcr-34-5-539.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40695661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comments on National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version). 《2022年中国国家乳腺癌诊疗指南》(英文版)评议
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.03
Xinguang Wang, Zhaoqing Fan
{"title":"Comments on <i>National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)</i>.","authors":"Xinguang Wang,&nbsp;Zhaoqing Fan","doi":"10.21147/j.issn.1000-9604.2022.05.03","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.05.03","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"451-452"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646461/pdf/cjcr-34-5-451.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version). 《中国国家胃癌诊疗指南2022》(英文版)评议
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.04
Jiahui Chen, Zhaode Bu, Jiafu Ji
{"title":"Comments on <i>National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)</i>.","authors":"Jiahui Chen,&nbsp;Zhaode Bu,&nbsp;Jiafu Ji","doi":"10.21147/j.issn.1000-9604.2022.05.04","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.05.04","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"453-455"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646458/pdf/cjcr-34-5-453.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Perspectives of laparoscopic surgery for gastric cancer. 腹腔镜手术治疗胃癌的展望。
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.12
Jeong Ho Song, Sang-Uk Han

Gastrectomy is the main treatment option for gastric cancer patients. Laparoscopic approach has become popular as an alternative to open method during the last decades, and clinical trials have revealed safety and feasibility in the short- and long-term outcomes of laparoscopic gastrectomy. The aim of this review is to summarize the results of prospective clinical trials and propose future perspectives for laparoscopic gastrectomy.

胃切除术是胃癌患者的主要治疗选择。在过去的几十年里,腹腔镜入路作为开放方法的一种替代方法越来越受欢迎,临床试验显示腹腔镜胃切除术的短期和长期结果的安全性和可行性。本综述的目的是总结前瞻性临床试验的结果,并提出腹腔镜胃切除术的未来前景。
{"title":"Perspectives of laparoscopic surgery for gastric cancer.","authors":"Jeong Ho Song,&nbsp;Sang-Uk Han","doi":"10.21147/j.issn.1000-9604.2022.05.12","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.05.12","url":null,"abstract":"<p><p>Gastrectomy is the main treatment option for gastric cancer patients. Laparoscopic approach has become popular as an alternative to open method during the last decades, and clinical trials have revealed safety and feasibility in the short- and long-term outcomes of laparoscopic gastrectomy. The aim of this review is to summarize the results of prospective clinical trials and propose future perspectives for laparoscopic gastrectomy.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"533-538"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646463/pdf/cjcr-34-5-533.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening: A multicenter randomized controlled trial in different resource settings in China. 评价宫颈癌筛查中高危人乳头瘤病毒阳性妇女的分诊策略:中国不同资源环境下的一项多中心随机对照试验
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.09
Le Dang, Linghua Kong, Yuqian Zhao, Yi Dai, Li Ma, Lihui Wei, Shulan Zhang, Jihong Liu, Mingrong Xi, Long Chen, Xianzhi Duan, Qing Xiao, Guzhalinuer Abulizi, Guonan Zhang, Ying Hong, Qi Zhou, Xing Xie, Li Li, Mayinuer Niyazi, Zhifen Zhang, Jiyu Tuo, Yiling Ding, Youlin Qiao, Jinghe Lang

Objective: We aimed to evaluate the effectiveness of different triage strategies for high-risk human papillomavirus (hrHPV)-positive women in primary healthcare settings in China.

Methods: This study was undertaken in 11 rural and 9 urban sites. Women aged 35-64 years old were enrolled. HrHPV-positive women were randomly allocated to liquid-based cytology (LBC), visual inspection with acetic acid and Lugol's iodine (VIA/VILI) (rural only) triage, or directly referred to colposcopy (direct COLP). At 24 months, hrHPV testing, LBC and VIA/VILI were conducted for combined screening.

Results: In rural sites, 1,949 hrHPV-positive women were analyzed. A total of 852, 218 and 480 women were randomly assigned to direct COLP, LBC and VIA/VILI. At baseline, colposcopy referral rates of LBC or VIA/VILI triage could be reduced by 70%-80%. LBC (n=3 and n=7) or VIA/VILI (n=8 and n=26) could significantly decrease the number of colposcopies needed to detect one cervical intraepithelial neoplasia (CIN) 2 or worse and CIN3+ compared with direct COLP (n=14 and n=23). For the 24-month cumulative detection rate of CIN2+, VIA/VILI triage was 0.50-fold compared with LBC triage and 0.46-fold with the direct COLP. When stratified by age, baseline LBC triage+ performed best (P<0.001), peaking among women aged 35-44 years (Ptrend=0.002). In urban sites, 1,728 women were hrHPV genotyping test positive. A total of 408, 571 and 568 women were randomly assigned to direct COLP for HPV16/18+, direct COLP for other hrHPV subtypes+, and LBC triage for other hrHPV subtypes+. LBC (n=12 and n=31) significantly decreased the number of colposcopies needed to detect one CIN2+ and CIN3+ compared with direct COLP (n=14 and n=44). HPV16/18+ increased the 24-month cumulative detection rate of CIN2+ (17.89%, P<0.001).

Conclusions: LBC triage for hrHPV-positive women in rural settings and direct COLP for HPV16/18+ women and LBC triage for other hrHPV subtype+ women in urban settings might be feasible strategies.

目的:我们旨在评估中国初级卫生保健机构对高危人乳头瘤病毒(hrHPV)阳性妇女不同分诊策略的有效性。方法:本研究在11个农村和9个城市进行。女性年龄在35-64岁之间。hrhpv阳性妇女被随机分配到液体细胞学检查(LBC),醋酸和卢戈尔碘目视检查(VIA/VILI)(仅限农村)分诊,或直接转介阴道镜检查(直接COLP)。在24个月时,进行hrHPV检测、LBC和VIA/VILI联合筛查。结果:在农村地区,分析了1949名hrhpv阳性妇女。共有852、218和480名妇女被随机分配到直接COLP、LBC和VIA/VILI组。在基线时,LBC或VIA/VILI分诊的阴道镜转诊率可降低70%-80%。与直接COLP (n=14和n=23)相比,LBC (n=3和n=7)或VIA/VILI (n=8和n=26)可显著减少检测1例宫颈上皮内瘤变(CIN) 2及以上和CIN3+所需的阴道镜检查次数。对于CIN2+的24个月累积检出率,VIA/VILI分诊是LBC分诊的0.50倍,是直接COLP的0.46倍。当按年龄分层时,基线LBC分诊+表现最佳(p趋势=0.002)。在城市地区,1728名妇女hrHPV基因分型检测呈阳性。共有408、571和568名妇女被随机分配到HPV16/18+的直接COLP,其他hrHPV亚型+的直接COLP,以及其他hrHPV亚型+的LBC分诊。与直接COLP (n=14和n=44)相比,LBC (n=12和n=31)显著减少了检测一种CIN2+和CIN3+所需的阴道镜检查次数。结论:农村地区hrHPV阳性妇女采用LBC分诊,城市地区HPV16/18+妇女采用直接COLP和其他hrHPV亚型+妇女采用LBC分诊可能是可行的策略。
{"title":"Evaluation of triage strategies for high-risk human papillomavirus-positive women in cervical cancer screening: A multicenter randomized controlled trial in different resource settings in China.","authors":"Le Dang,&nbsp;Linghua Kong,&nbsp;Yuqian Zhao,&nbsp;Yi Dai,&nbsp;Li Ma,&nbsp;Lihui Wei,&nbsp;Shulan Zhang,&nbsp;Jihong Liu,&nbsp;Mingrong Xi,&nbsp;Long Chen,&nbsp;Xianzhi Duan,&nbsp;Qing Xiao,&nbsp;Guzhalinuer Abulizi,&nbsp;Guonan Zhang,&nbsp;Ying Hong,&nbsp;Qi Zhou,&nbsp;Xing Xie,&nbsp;Li Li,&nbsp;Mayinuer Niyazi,&nbsp;Zhifen Zhang,&nbsp;Jiyu Tuo,&nbsp;Yiling Ding,&nbsp;Youlin Qiao,&nbsp;Jinghe Lang","doi":"10.21147/j.issn.1000-9604.2022.05.09","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.05.09","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to evaluate the effectiveness of different triage strategies for high-risk human papillomavirus (hrHPV)-positive women in primary healthcare settings in China.</p><p><strong>Methods: </strong>This study was undertaken in 11 rural and 9 urban sites. Women aged 35-64 years old were enrolled. HrHPV-positive women were randomly allocated to liquid-based cytology (LBC), visual inspection with acetic acid and Lugol's iodine (VIA/VILI) (rural only) triage, or directly referred to colposcopy (direct COLP). At 24 months, hrHPV testing, LBC and VIA/VILI were conducted for combined screening.</p><p><strong>Results: </strong>In rural sites, 1,949 hrHPV-positive women were analyzed. A total of 852, 218 and 480 women were randomly assigned to direct COLP, LBC and VIA/VILI. At baseline, colposcopy referral rates of LBC or VIA/VILI triage could be reduced by 70%-80%. LBC (n=3 and n=7) or VIA/VILI (n=8 and n=26) could significantly decrease the number of colposcopies needed to detect one cervical intraepithelial neoplasia (CIN) 2 or worse and CIN3+ compared with direct COLP (n=14 and n=23). For the 24-month cumulative detection rate of CIN2+, VIA/VILI triage was 0.50-fold compared with LBC triage and 0.46-fold with the direct COLP. When stratified by age, baseline LBC triage+ performed best (P<0.001), peaking among women aged 35-44 years (P<sub>trend</sub>=0.002). In urban sites, 1,728 women were hrHPV genotyping test positive. A total of 408, 571 and 568 women were randomly assigned to direct COLP for HPV16/18+, direct COLP for other hrHPV subtypes+, and LBC triage for other hrHPV subtypes+. LBC (n=12 and n=31) significantly decreased the number of colposcopies needed to detect one CIN2+ and CIN3+ compared with direct COLP (n=14 and n=44). HPV16/18+ increased the 24-month cumulative detection rate of CIN2+ (17.89%, P<0.001).</p><p><strong>Conclusions: </strong>LBC triage for hrHPV-positive women in rural settings and direct COLP for HPV16/18+ women and LBC triage for other hrHPV subtype+ women in urban settings might be feasible strategies.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"496-509"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646459/pdf/cjcr-34-5-496.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colorectal cancer burden, trends and risk factors in China: A review and comparison with the United States. 中国结直肠癌的负担、趋势和风险因素:回顾并与美国进行比较。
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.08
Qianru Li, Hongliang Wu, Maomao Cao, He Li, Siyi He, Fan Yang, Xinxin Yan, Shaoli Zhang, Yi Teng, Changfa Xia, Ji Peng, Wanqing Chen

Objective: China and the United States (the U.S.) have the heaviest colorectal cancer (CRC) burden with considerable variations in temporal trends. This study aims to analyze the temporal patterns of CRC burden and its risk factors in China and the U.S. across the past three decades.

Methods: Data were extracted from the Global Burden of Disease (GBD) Study in 2019, including cases, deaths, disability-adjusted life-years (DALYs), age-standardized rate (ASR), and summary exposure value (SEV) of CRC in China and the U.S. between 1990 and 2019. Annual average percentage changes (AAPCs) of CRC burden were calculated using the Joinpoint regression model. The mortality in CRC attributable to potential risk factors was characterized by countries, gender, and age groups.

Results: In 2019, there were 607,900 and 227,241 CRC cases, and 261,777 and 84,026 CRC deaths in China and the U.S., respectively. The age-standardized incidence rate (ASIR) was 30.55 per 100,000 in China and 41.86 per 100,000 in the U.S., and the age-standardized mortality rate (ASMR) was 13.86 per 100,000 in China and 14.77 per 100,000 in the U.S. CRC incidence, mortality, and DALY rate in the U.S. showed downward trends in the past three decades (AAPC=-0.47, -1.06, and -0.88, respectively), while upward trends were observed in China (AAPC=3.11, 1.05, and 0.91, respectively). Among the cause of CRC, the leading risk factor contributing to CRC death was low milk in China and smoking in the U.S., respectively.

Conclusions: From 1990 to 2019, the burden of CRC in China increased dramatically, particularly for males and middle-aged and elderly people. The management of the major risk factors associated with the high burden of CRC should be enhanced.

目的:中国和美国是结直肠癌(CRC)发病率最高的国家,但这两个国家的CRC发病率在时间趋势上存在很大差异。本研究旨在分析中国和美国在过去三十年中 CRC 负担及其风险因素的时间模式:数据来源于2019年全球疾病负担(GBD)研究,包括1990年至2019年间中国和美国的CRC病例数、死亡数、残疾调整生命年数(DALYs)、年龄标准化率(ASR)和总暴露值(SEV)。使用Joinpoint回归模型计算了CRC负担的年均百分比变化(AAPCs)。潜在风险因素导致的 CRC 死亡率按国家、性别和年龄组划分:2019年,中国和美国分别有607,900例和227,241例CRC病例,以及261,777例和84,026例CRC死亡病例。中国的年龄标准化发病率(ASIR)为30.55/10万,美国为41.86/10万、在过去三十年中,美国的 CRC 发病率、死亡率和 DALY 率呈下降趋势(AAPC=-0.47、-1.06 和 -0.88),而中国则呈上升趋势(AAPC=3.11、1.05 和 0.91)。在导致 CRC 死亡的原因中,中国的低脂牛奶和美国的吸烟分别是导致 CRC 死亡的首要风险因素:从 1990 年到 2019 年,中国的 CRC 负担急剧增加,尤其是男性和中老年人。应加强对与 CRC 高负担相关的主要危险因素的管理。
{"title":"Colorectal cancer burden, trends and risk factors in China: A review and comparison with the United States.","authors":"Qianru Li, Hongliang Wu, Maomao Cao, He Li, Siyi He, Fan Yang, Xinxin Yan, Shaoli Zhang, Yi Teng, Changfa Xia, Ji Peng, Wanqing Chen","doi":"10.21147/j.issn.1000-9604.2022.05.08","DOIUrl":"10.21147/j.issn.1000-9604.2022.05.08","url":null,"abstract":"<p><strong>Objective: </strong>China and the United States (the U.S.) have the heaviest colorectal cancer (CRC) burden with considerable variations in temporal trends. This study aims to analyze the temporal patterns of CRC burden and its risk factors in China and the U.S. across the past three decades.</p><p><strong>Methods: </strong>Data were extracted from the Global Burden of Disease (GBD) Study in 2019, including cases, deaths, disability-adjusted life-years (DALYs), age-standardized rate (ASR), and summary exposure value (SEV) of CRC in China and the U.S. between 1990 and 2019. Annual average percentage changes (AAPCs) of CRC burden were calculated using the Joinpoint regression model. The mortality in CRC attributable to potential risk factors was characterized by countries, gender, and age groups.</p><p><strong>Results: </strong>In 2019, there were 607,900 and 227,241 CRC cases, and 261,777 and 84,026 CRC deaths in China and the U.S., respectively. The age-standardized incidence rate (ASIR) was 30.55 per 100,000 in China and 41.86 per 100,000 in the U.S., and the age-standardized mortality rate (ASMR) was 13.86 per 100,000 in China and 14.77 per 100,000 in the U.S. CRC incidence, mortality, and DALY rate in the U.S. showed downward trends in the past three decades (AAPC=-0.47, -1.06, and -0.88, respectively), while upward trends were observed in China (AAPC=3.11, 1.05, and 0.91, respectively). Among the cause of CRC, the leading risk factor contributing to CRC death was low milk in China and smoking in the U.S., respectively.</p><p><strong>Conclusions: </strong>From 1990 to 2019, the burden of CRC in China increased dramatically, particularly for males and middle-aged and elderly people. The management of the major risk factors associated with the high burden of CRC should be enhanced.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"483-495"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646460/pdf/cjcr-34-5-483.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version). 中国国家前列腺癌诊疗指南2022(英文版)点评
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.05
Yong Yang
{"title":"Comments on <i>National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)</i>.","authors":"Yong Yang","doi":"10.21147/j.issn.1000-9604.2022.05.05","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.05.05","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"456-457"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646454/pdf/cjcr-34-5-456.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Characteristics of lymph node stations/basins metastasis and construction and validation of a preoperative combination prediction model that accurately excludes lymph node metastasis in early gastric cancer. 早期胃癌淋巴结站/基底转移的特征以及准确排除淋巴结转移的术前联合预测模型的构建和验证。
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.11
Mengyu Feng, Jingtao Wei, Ke Ji, Yinan Zhang, Heli Yang, Xiaojiang Wu, Ji Zhang, Zhaode Bu, Jiafu Ji

Objective: To explore the candidate indications for function-preserving curative gastrectomy and sentinel lymph node navigation surgery in early gastric cancer (EGC).

Methods: The clinicopathological data of 561 patients with EGC who underwent radical gastrectomy for gastric cancer at Peking University Cancer Hospital from November 2010 to November 2020 with postoperative pathological stage pT1 and complete examination data, were collected. Pearson's Chi-square test was used and binary logistic regression was employed for univariate and multivariate analyses. Combined analysis of multiple risk and protective factors for lymph node metastasis (LNM) of EGC was performed. A negative predictive value (NPV) combination model was built and validated.

Results: LNM occurred in 85 of 561 patients with EGC, and the LNM rate was 15.15%. NPV for LNM reached 100% based on three characteristics, including ulcer-free, moderately well differentiation and patient <65 years old or tumor located at the proximal 1/3 of the stomach. Regarding lymphatic basin metastasis, multivariate analysis showed that the metastatic proportion of the left gastric artery lymphatic basin was significantly higher in male patients compared with female patients (65.96% vs. 38.89%, P<0.05). The proportion of right gastroepiploic artery lymphatic basin metastasis in patients with a maximum tumor diameter >2 cm was significantly greater than that noted in patients with a maximum tumor diameter ≤2 cm (60.78% vs. 28.13%, P<0.05).

Conclusions: Characteristics of lymph node stations/basins metastasis will facilitate precise lymph node resection. The NPV for LNM reaches 100% based on the following two conditions: young and middle-aged EGC patients, well-differentiated tumors, and without ulcers; or well-differentiated tumors, without ulcers, and tumors located in the proximal stomach. These findings can be used as the recommended indications for function-preserving curative gastrectomy and sentinel lymph node navigation surgery.

目的探讨早期胃癌(EGC)保留功能根治性胃切除术和前哨淋巴结导航手术的适应症:收集2010年11月至2020年11月在北京大学肿瘤医院接受胃癌根治术的561例EGC患者的临床病理资料,这些患者术后病理分期为pT1,且检查资料完整。采用皮尔逊卡方检验和二元逻辑回归进行单变量和多变量分析。对EGC淋巴结转移(LNM)的多种风险和保护因素进行了综合分析。建立并验证了阴性预测值(NPV)组合模型:结果:561例EGC患者中有85例发生了淋巴结转移,淋巴结转移率为15.15%。基于无溃疡、中度分化和患者对 38.89%、P2 cm 这三个特征,LNM 的 NPV 达到 100%,明显高于肿瘤最大直径≤2 cm 的患者(60.78% 对 28.13%):淋巴结站/基底转移的特征将有助于精确切除淋巴结。在以下两种情况下,LNM 的 NPV 达到 100%:中青年 EGC 患者、肿瘤分化良好且无溃疡;或肿瘤分化良好、无溃疡且肿瘤位于胃近端。这些结果可作为保留功能的根治性胃切除术和前哨淋巴结导航手术的推荐适应症。
{"title":"Characteristics of lymph node stations/basins metastasis and construction and validation of a preoperative combination prediction model that accurately excludes lymph node metastasis in early gastric cancer.","authors":"Mengyu Feng, Jingtao Wei, Ke Ji, Yinan Zhang, Heli Yang, Xiaojiang Wu, Ji Zhang, Zhaode Bu, Jiafu Ji","doi":"10.21147/j.issn.1000-9604.2022.05.11","DOIUrl":"10.21147/j.issn.1000-9604.2022.05.11","url":null,"abstract":"<p><strong>Objective: </strong>To explore the candidate indications for function-preserving curative gastrectomy and sentinel lymph node navigation surgery in early gastric cancer (EGC).</p><p><strong>Methods: </strong>The clinicopathological data of 561 patients with EGC who underwent radical gastrectomy for gastric cancer at Peking University Cancer Hospital from November 2010 to November 2020 with postoperative pathological stage pT1 and complete examination data, were collected. Pearson's Chi-square test was used and binary logistic regression was employed for univariate and multivariate analyses. Combined analysis of multiple risk and protective factors for lymph node metastasis (LNM) of EGC was performed. A negative predictive value (NPV) combination model was built and validated.</p><p><strong>Results: </strong>LNM occurred in 85 of 561 patients with EGC, and the LNM rate was 15.15%. NPV for LNM reached 100% based on three characteristics, including ulcer-free, moderately well differentiation and patient <65 years old or tumor located at the proximal 1/3 of the stomach. Regarding lymphatic basin metastasis, multivariate analysis showed that the metastatic proportion of the left gastric artery lymphatic basin was significantly higher in male patients compared with female patients (65.96% <i>vs.</i> 38.89%, P<0.05). The proportion of right gastroepiploic artery lymphatic basin metastasis in patients with a maximum tumor diameter >2 cm was significantly greater than that noted in patients with a maximum tumor diameter ≤2 cm (60.78% <i>vs</i>. 28.13%, P<0.05).</p><p><strong>Conclusions: </strong>Characteristics of lymph node stations/basins metastasis will facilitate precise lymph node resection. The NPV for LNM reaches 100% based on the following two conditions: young and middle-aged EGC patients, well-differentiated tumors, and without ulcers; or well-differentiated tumors, without ulcers, and tumors located in the proximal stomach. These findings can be used as the recommended indications for function-preserving curative gastrectomy and sentinel lymph node navigation surgery.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"519-532"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646451/pdf/cjcr-34-5-519.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation between imaging features on computed tomography and combined positive score of PD-L1 expression in patients with gastric cancer. 胃癌患者计算机断层成像特征与PD-L1表达联合阳性评分的相关性
Pub Date : 2022-10-30 DOI: 10.21147/j.issn.1000-9604.2022.05.10
Zhilong Wang, Yinkui Wang, Xiaoting Li, Yanling Li, Zhaode Bu, Zhongwu Li, Yingshi Sun, Jiafu Ji

Objective: To explore the correlation between computed tomography (CT) features and combined positive score (CPS) of programmed cell death ligand 1 (PD-L1) expression in patients with gastric cancer (GC).

Methods: This study reviewed an institutional database of patients who underwent GC operation without neoadjuvant chemotherapy between December 2019 and September 2020. The CPS results of PD-L1 expression of postoperative histological examination were recorded by pathology. Baseline CT features were measured, and their correlation with CPS 5 or 10 score groups of PD-L1 expression was analyzed.

Results: Data for 153 patients with GC were collected. Among them, 124 were advanced GC patients, and 29 were early GC patients. None of the CT features significantly differed between CPS groups with a cutoff score of 5 and a score of 10 in patients with early GC. In advanced GC, the presence of lymph nodes with short diameters >10 mm was significantly different (P=0.024) between the CPS<5 and CPS≥5 groups. CT features such as tumor attenuation in the arterial phase, long and short diameter of the largest lymph node, the sum of long diameter of the two largest lymph nodes, the sum of short diameter of the two largest lymph nodes, and the presence of lymph nodes with short diameters >10 mm significantly differed between the CPS<10 and CPS≥10 groups in advanced GC. The sensitivity, specificity and area under receiver operating characteristic (ROC) curve of logistic regression model for predicting CPS≥10 was 71.7%, 50.0% and 0.671, respectively. Microsatellite instability (MSI) status was significantly different in CPS groups with cutoff score of 5 and 10 in advanced GC patients.

Conclusions: CT findings of advanced GC patients with CPS≥10 showed greater arterial phase enhancement and larger lymph nodes. CT has the potential to help screen patients suitable for immunotherapy.

目的:探讨胃癌(GC)患者计算机断层扫描(CT)特征与程序性细胞死亡配体1 (PD-L1)表达联合阳性评分(CPS)的相关性。方法:本研究回顾了2019年12月至2020年9月期间接受GC手术且未进行新辅助化疗的患者的机构数据库。病理记录术后组织检查PD-L1表达的CPS结果。测量基线CT特征,并分析其与CPS 5或10评分组PD-L1表达的相关性。结果:收集了153例胃癌患者的资料。其中晚期胃癌124例,早期胃癌29例。早期GC患者的截止评分为5分和10分,CPS组之间的CT特征均无显著差异。在晚期胃癌患者中,短径>10 mm的淋巴结在两组之间存在显著差异(P=0.024),两组之间存在显著差异(P=0.024)。结论:CPS≥10的晚期胃癌患者的CT表现为动脉期强化明显,淋巴结较大。CT有可能帮助筛选适合免疫治疗的患者。
{"title":"Correlation between imaging features on computed tomography and combined positive score of PD-L1 expression in patients with gastric cancer.","authors":"Zhilong Wang,&nbsp;Yinkui Wang,&nbsp;Xiaoting Li,&nbsp;Yanling Li,&nbsp;Zhaode Bu,&nbsp;Zhongwu Li,&nbsp;Yingshi Sun,&nbsp;Jiafu Ji","doi":"10.21147/j.issn.1000-9604.2022.05.10","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.05.10","url":null,"abstract":"<p><strong>Objective: </strong>To explore the correlation between computed tomography (CT) features and combined positive score (CPS) of programmed cell death ligand 1 (PD-L1) expression in patients with gastric cancer (GC).</p><p><strong>Methods: </strong>This study reviewed an institutional database of patients who underwent GC operation without neoadjuvant chemotherapy between December 2019 and September 2020. The CPS results of PD-L1 expression of postoperative histological examination were recorded by pathology. Baseline CT features were measured, and their correlation with CPS 5 or 10 score groups of PD-L1 expression was analyzed.</p><p><strong>Results: </strong>Data for 153 patients with GC were collected. Among them, 124 were advanced GC patients, and 29 were early GC patients. None of the CT features significantly differed between CPS groups with a cutoff score of 5 and a score of 10 in patients with early GC. In advanced GC, the presence of lymph nodes with short diameters >10 mm was significantly different (P=0.024) between the CPS<5 and CPS≥5 groups. CT features such as tumor attenuation in the arterial phase, long and short diameter of the largest lymph node, the sum of long diameter of the two largest lymph nodes, the sum of short diameter of the two largest lymph nodes, and the presence of lymph nodes with short diameters >10 mm significantly differed between the CPS<10 and CPS≥10 groups in advanced GC. The sensitivity, specificity and area under receiver operating characteristic (ROC) curve of logistic regression model for predicting CPS≥10 was 71.7%, 50.0% and 0.671, respectively. Microsatellite instability (MSI) status was significantly different in CPS groups with cutoff score of 5 and 10 in advanced GC patients.</p><p><strong>Conclusions: </strong>CT findings of advanced GC patients with CPS≥10 showed greater arterial phase enhancement and larger lymph nodes. CT has the potential to help screen patients suitable for immunotherapy.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":" ","pages":"510-518"},"PeriodicalIF":0.0,"publicationDate":"2022-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646453/pdf/cjcr-34-5-510.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40696181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
National guidelines for diagnosis and treatment of melanoma 2022 in China (English version). 中国国家黑色素瘤诊疗指南2022(英文版)。
Pub Date : 2022-08-30 DOI: 10.21147/j.issn.1000-9604.2022.04.02
National Health Commission Of The People's Republic Of China
{"title":"National guidelines for diagnosis and treatment of melanoma 2022 in China (English version).","authors":"National Health Commission Of The People's Republic Of China","doi":"10.21147/j.issn.1000-9604.2022.04.02","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.04.02","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 4","pages":"335-342"},"PeriodicalIF":0.0,"publicationDate":"2022-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468019/pdf/cjcr-34-4-335.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33489673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1